BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Chronic Pancreatitis Market – Forecast to 2030,’ thoroughly examines the Chronic Pancreatitis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Cystinuria Market – Forecast to 2030,’ thoroughly examines the Cystinuria industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Dravet Syndrome Market – Forecast to 2030,’ thoroughly examines the Dravet Syndrome industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Exocrine Pancreatic Insufficiency Market – Forecast to 2030,’ thoroughly examines the Exocrine Pancreatic Insufficiency industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Hyperlipidemia Market – Forecast to 2030,’ thoroughly examines the Hyperlipidemia industry to provide essential data & information for the targeted readers.

According to Vision Research Reports, the global Interventional Radiology market size surpassed at US$ 19 bn in 2021 and is expected to grow at a CAGR of 5.5% from 2022 to 2030.

According to the report, the healthcare informatics market size was valued at US$ 31 Bn in 2020 and is expected to reach US$ 100 billion by 2030, expanding growth at a noteworthy CAGR of 12.1% from 2021 to 2030.

Modifi Biosciences announced that the journal Science has published a critical study validating the company’s novel oncology platform based on new classes of molecules that exploit tumor-associated DNA repair defects through direct cancer cell DNA modification.

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, plans to report second quarter 2022 financial results and corporate highlights after the close of market on Thursday, August 4, 2022.

Sera Prognostics Inc. today announced that it will report second quarter fiscal year 2022 financial results on Wednesday, August 10, 2022, after the close of the markets.